Stefan Müllner
InvestorDr. at fundamenta Life Science
About
Chemist and biochemist (PhD) with a career spanning Hoechst Pharma, Henkel (VP Enzyme Technology), venture capital, and CEO of Protagen until 2016; advises technology companies and investors on product and business strategy in life sciences.
